Skip to contentV
Vaxart, Inc.
V
VXRTVaxart, Inc. Q2 2024 · 10-Q
Revenue$6.40M$6.40M+371.4% vs Q2 2023 Net Income-$16.47M-$16.47MN/M vs Q2 2023 EPS, diluted—
Operating Income-$16,256,000N/M Operating Cash Flowderived-$12,027,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
Free Cash Flowderived-$12,397,000N/M Margins · derivedOperating margin-254.0%+1443.6 pt vs Q2 2023
Net margin-257.2%+1403.3 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end